# WP1066 in Children With Refractory and Progressive or Recurrent Malignant Brain Tumors

> **NCT04334863** · PHASE1 · COMPLETED · sponsor: **Emory University** · enrollment: 10 (actual)

## Conditions studied

- Brain Tumor
- Medulloblastoma
- Brain Metastases

## Interventions

- **DRUG:** WP1066

## Key facts

- **NCT ID:** NCT04334863
- **Lead sponsor:** Emory University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-05-04
- **Primary completion:** 2023-02-03
- **Final completion:** 2023-02-03
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2023-02-21

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04334863

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04334863, "WP1066 in Children With Refractory and Progressive or Recurrent Malignant Brain Tumors". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04334863. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*